Kim YH - Search Results

1

Development of a Novel Biomarker for the Progression of Idiopathic Pulmonary Fibrosis.

Yeo HJ, Ha M, Shin DH, Lee HR, Kim YH, Cho WH. Yeo HJ, et al. Among authors: kim yh. Int J Mol Sci. 2024 Jan 2;25(1):599. doi: 10.3390/ijms25010599. Int J Mol Sci. 2024. PMID: 38203769 Free PMC article.

2

TMEM18: A Novel Prognostic Marker in Acute Myeloid Leukemia.

Ha M, Kim JY, Han ME, Kim GH, Park SY, Jeong DC, Oh SO, Kim YH. Ha M, et al. Among authors: kim jy, kim yh, kim gh. Acta Haematol. 2018;140(2):71-76. doi: 10.1159/000492742. Epub 2018 Sep 10. Acta Haematol. 2018. PMID: 30199869

3

Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis.

Ha M, Han ME, Kim JY, Jeong DC, Oh SO, Kim YH. Ha M, et al. Among authors: kim jy, kim yh. J Cell Biochem. 2019 Mar;120(3):3672-3678. doi: 10.1002/jcb.27645. Epub 2018 Sep 11. J Cell Biochem. 2019. PMID: 30203488

4

ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: A retrospective multicohort study.

Cho SH, Ha M, Cho YH, Ryu JH, Yang K, Lee KH, Han ME, Oh SO, Kim YH. Cho SH, et al. Among authors: kim yh. Ann Hepatobiliary Pancreat Surg. 2018 Nov;22(4):305-309. doi: 10.14701/ahbps.2018.22.4.305. Epub 2018 Nov 27. Ann Hepatobiliary Pancreat Surg. 2018. PMID: 30588520 Free PMC article.

5

Evaluation of the prognostic significances of γ-secretase genes in pancreatic cancer.

Jeon YH, Ha M, Kim SW, Kim MJ, Lee CS, Oh CK, Han ME, Oh SO, Kim YH. Jeon YH, et al. Among authors: kim yh, kim sw, kim mj. Oncol Lett. 2019 May;17(5):4614-4620. doi: 10.3892/ol.2019.10113. Epub 2019 Mar 5. Oncol Lett. 2019. PMID: 30944650 Free PMC article.

6

VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma.

Ha M, Jeong H, Roh JS, Lee B, Lee D, Han ME, Oh SO, Sohn DH, Kim YH. Ha M, et al. Among authors: kim yh. Anim Cells Syst (Seoul). 2019 Mar 1;23(2):112-117. doi: 10.1080/19768354.2019.1583126. eCollection 2019 Apr. Anim Cells Syst (Seoul). 2019. PMID: 30949398 Free PMC article.

7

Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma.

Goh TS, Ha M, Lee JS, Jeong DC, Jung ES, Han ME, Kim YH, Oh SO. Goh TS, et al. Among authors: kim yh. Onco Targets Ther. 2019 Apr 15;12:2853-2859. doi: 10.2147/OTT.S202101. eCollection 2019. Onco Targets Ther. 2019. PMID: 31043796 Free PMC article.

8

Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis.

Ha M, Moon H, Choi D, Kang W, Kim JH, Lee KJ, Park D, Kang CD, Oh SO, Han ME, Kim YH, Lee D. Ha M, et al. Among authors: kim yh, kim jh. Front Genet. 2019 Apr 17;10:355. doi: 10.3389/fgene.2019.00355. eCollection 2019. Front Genet. 2019. PMID: 31057605 Free PMC article.

9

DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts.

Ha M, Jeong H, Roh JS, Lee B, Han ME, Oh SO, Sohn DH, Kim YH. Ha M, et al. Among authors: kim yh. Urol Oncol. 2019 Oct;37(10):735-741. doi: 10.1016/j.urolonc.2019.07.007. Epub 2019 Jul 31. Urol Oncol. 2019. PMID: 31377166

10

SIRT1 is dispensable for maturation of hematopoietic stem cell in the bone marrow niche.

Park SM, Kim J, Hong CM, Shin DH, Kim JY, Park DY, Sohn DH, Kim YH, Kwon SM, Kim JH, Bae SS, Kim K, Kim CD, Kang CD, Lee D. Park SM, et al. Among authors: kim jy, kim yh, kim cd, kim j, kim jh, kim k. Exp Ther Med. 2019 Sep;18(3):2341-2345. doi: 10.3892/etm.2019.7813. Epub 2019 Jul 25. Exp Ther Med. 2019. PMID: 31452717 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,470 results

Search Page